New versions of psychedelic drugs without hallucinogenic side effects known as neuroplastogens have the potential to repair damaged neural circuitry in patients with depression, schizophrenia, dementia, and other illnesses with rapid and long-lasting results. Guest: David E. Olson, Ph.D., Director, UC Davis Institute for Psychedelics and Neurotherapeutics.